What does CUSIP 10919W108 represent in this 13F holders report?

CUSIP 10919W108 is the security identifier for DRUG - BRIGHT MINDS BIOSCIENCES INC - COM used to aggregate holder disclosures.

How many institutions held DRUG - BRIGHT MINDS BIOSCIENCES INC - COM in Q1 2022?

10 institutional investors reported DRUG - BRIGHT MINDS BIOSCIENCES INC - COM for Q1 2022. Use the holders table for investor-level position and value details.

BRIGHT MINDS BIOSCIENCES INC - COM (DRUG)

CUSIP: 10919W108

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / COM
Total 13F shares: 414,016
Total 13F value: $628,000
Share change: -497,081
SEC-reported price per share: $1.52
Number of holders: 10
Value change: -$1,883,349
Number of buys: 6
Number of sells: 1

Security key

10919W108

Report period

Q1 2022

Institutions

Top holders

DRUG full security history Ownership snapshot Full 13F holder table BRIGHT MINDS BIOSCIENCES INC. SEC filings BRIGHT MINDS BIOSCIENCES INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of DRUG - BRIGHT MINDS BIOSCIENCES INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

0/9

Latest evidence

31 Dec 2021

13F Highest disclosed value: $2,131,000 9 rows are not safely comparable across share classes. Showing 1-6 of 9 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $2.13M.

0 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Disclosed position value Top 5

ORBIMED ADVISORS LLC $2.13M

Ikarian Capital, LLC $317K

AdvisorShares Investments LLC $304K

QUATTRO FINANCIAL ADVISORS LLC $67K

Checchi Capital Advisers, LLC $45K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 9 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$2,131,000 660,600 shares	—	31 Dec 2021
Ikarian Capital, LLC	13F Company 13F	— denominator unverified	$317,000 100,000 shares	—	31 Dec 2021
AdvisorShares Investments LLC	13F Company 13F	— denominator unverified	$304,000 95,942 shares	—	31 Dec 2021
QUATTRO FINANCIAL ADVISORS LLC	13F Company 13F	— denominator unverified	$67,000 21,150 shares	—	31 Dec 2021
Checchi Capital Advisers, LLC	13F Company 13F	— denominator unverified	$45,000 14,138 shares	—	31 Dec 2021
BOOTHBAY FUND MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$35,000 11,040 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

414,016

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %